These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9747887)

  • 1. The role of T cell receptor dimerization for T cell antagonism and T cell specificity.
    Salzmann M; Bachmann MF
    Mol Immunol; 1998 Apr; 35(5):271-7. PubMed ID: 9747887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.
    Donermeyer DL; Weber KS; Kranz DM; Allen PM
    J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR.
    Holmberg K; Mariathasan S; Ohteki T; Ohashi PS; Gascoigne NR
    J Immunol; 2003 Sep; 171(5):2427-34. PubMed ID: 12928390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.
    Bachmann MF; Speiser DE; Zakarian A; Ohashi PS
    Eur J Immunol; 1998 Oct; 28(10):3110-9. PubMed ID: 9808179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
    Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
    J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPU-Accelerated Discovery of Pathogen-Derived Molecular Mimics of a T-Cell Insulin Epitope.
    Whalley T; Dolton G; Brown PE; Wall A; Wooldridge L; van den Berg H; Fuller A; Hopkins JR; Crowther MD; Attaf M; Knight RR; Cole DK; Peakman M; Sewell AK; Szomolay B
    Front Immunol; 2020; 11():296. PubMed ID: 32184781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction.
    Chung CD; Patel VP; Moran M; Lewis LA; Miceli MC
    J Immunol; 2000 Oct; 165(7):3722-9. PubMed ID: 11034377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response.
    Reichstetter S; Ettinger RA; Liu AW; Gebe JA; Nepom GT; Kwok WW
    J Immunol; 2000 Dec; 165(12):6994-8. PubMed ID: 11120826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].
    Boniface JJ; Rabinowitz JD; Wülfing C; Hampl J; Reich Z; Altman JD; Kantor RM; Beeson C; McConnell HM; Davis MM
    Immunity; 1998 Oct; 9(4):459-66. PubMed ID: 9806632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific T-cell activation in an unspecific T-cell repertoire.
    Van Den Berg HA; Molina-París C; Sewell AK
    Sci Prog; 2011; 94(Pt 3):245-64. PubMed ID: 22026148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells.
    Yang W; Grey HM
    J Immunol; 2003 May; 170(9):4532-8. PubMed ID: 12707330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anergy induction by dimeric TCR ligands.
    Appel H; Seth NP; Gauthier L; Wucherpfennig KW
    J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the strength of ligand antagonism in TCR triggering.
    Van Den Berg HA; Burroughs NJ; Rand DA
    Bull Math Biol; 2002 Jul; 64(4):781-808. PubMed ID: 12216421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-peptide/MHC and TCR antagonism: physiological role and therapeutic potential.
    Vukmanović S; Santori FR
    Cell Immunol; 2005 Feb; 233(2):75-84. PubMed ID: 15950208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands.
    Alam SM; Davies GM; Lin CM; Zal T; Nasholds W; Jameson SC; Hogquist KA; Gascoigne NR; Travers PJ
    Immunity; 1999 Feb; 10(2):227-37. PubMed ID: 10072075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular components of T-cell recognition.
    Jorgensen JL; Reay PA; Ehrich EW; Davis MM
    Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.